<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Treatment of urinary tract infection due to &lt;em&gt;Enterococcus&lt;/em&gt; spp</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Treatment of urinary tract infection due to <em>Enterococcus</em> spp</h1>
<div class="graphic"><div class="figure"><div class="ttl">Treatment of urinary tract infection due to <em>Enterococcus</em> spp</div><div class="cntnt"><table cellspacing="0"><colgroup width="40%"></colgroup><colgroup width="60%"></colgroup> <tbody> <tr> <td class="subtitle1_left">Regimen (depending on susceptibility)</td> <td class="subtitle1_left">Adult dose</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Simple cystitis</td> </tr> <tr> <td class="subtitle3_left" colspan="2">Preferred oral agents</td> </tr> <tr> <td class="indent2">Amoxicillin</td> <td>500 mg orally 3 times daily for 5 days</td> </tr> <tr> <td class="indent2">Nitrofurantoin*</td> <td>100 mg (monohydrate/macrocrystals [Macrobid]) twice daily for 5 days</td> </tr> <tr> <td class="indent2">Fosfomycin</td> <td>3 g (single dose)</td> </tr> <tr> <td class="subtitle3_left" colspan="2">Alternative oral agents</td> </tr> <tr> <td class="indent2">Levofloxacin</td> <td>250 mg orally once daily for 3 days</td> </tr> <tr> <td class="indent2">Linezolid</td> <td>600 mg orally twice daily for 5 days</td> </tr> <tr> <td class="subtitle3_left" colspan="2">Alternative agents for patients unable to tolerate oral therapy</td> </tr> <tr> <td class="indent2">Ampicillin</td> <td>1 g IV every 6 hours for 5 days</td> </tr> <tr> <td class="indent2">Vancomycin, daptomycin, or linezolid</td> <td>Dosing as summarized below</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Complicated urinary tract infection<sup>¶</sup></td> </tr> <tr> <td class="subtitle3_left" colspan="2">Preferred agents</td> </tr> <tr> <td class="indent2">Ampicillin</td> <td>2 g IV every 6 hours</td> </tr> <tr> <td class="subtitle3_left" colspan="2">Alternative agents</td> </tr> <tr> <td class="indent2">Vancomycin</td> <td>Initial dose 15 mg/kg/dose IV every 12 hours, not to exceed 2 g per dose; subsequent dosing guided by serum trough concentration monitoring<sup>Δ</sup></td> </tr> <tr> <td class="indent2">Levofloxacin</td> <td>750 mg IV or orally once daily</td> </tr> <tr> <td class="indent2">Linezolid</td> <td>600 mg orally or intravenously twice daily</td> </tr> <tr> <td class="indent2">Daptomycin</td> <td>8 mg/kg IV every 24 hours</td> </tr> </tbody></table></div><div class="graphic_lgnd">Regimens are for patients with infection due to susceptible isolates in the setting of normal renal function. Refer to UpToDate topic on treatment of enterococcal urinary tract infections for further discussion.</div><div class="graphic_footnotes"><p>IV: intravenously.</p>
<p>* Nitrofurantoin should be avoided if the creatinine clearance is &lt;30 mL/minute. Taking the oral suspension with food is preferred. A higher daily dose of nitrofurantoin oral suspension of macrocrystals is suggested in children ≤12 years (relative to adults and children &gt;12 years) due to formulation differences and resultant urinary tract concentrations.</p>
<p>¶ Results of urine culture and susceptibility testing should be used to tailor the regimen, including switching from a parenteral to an oral regimen once symptoms have improved. Appropriate oral agents to complete treatment for complicated enterococcal urinary tract infection include fluoroquinolones (levofloxacin 750 mg orally once daily) for 5 to 7 days, amoxicillin (1 g orally 3 to 4 times daily; some UpToDate contributors prefer to use lower doses) for 10 to 14 days, or linezolid (600 mg orally twice daily for 5 to 7 days).</p>
Δ There are no data on pharmacologic targets for vancomycin dosing in vancomycin-susceptible enterococcal urinary tract infections. Since vancomycin is excreted into the urine, elevated trough levels (&gt;15 mg/L) are likely not needed and may result in nephrotoxicity. A loading dose and/or higher pharmacologic targets may be considered as guided by the overall condition of the patient or a concern for concurrent infection due to another pathogen (eg, methicillin-resistant <em>Staphylococcus aureus</em>).</div><div id="graphicVersion">Graphic 73620 Version 18.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
